Med tech industry applauds planned US-EU trade negotiations
21 June 2013
The medical technology industry associations AdvaMed, COCIR, MITA
and MedTech Europe have applauded the announcement at the G8 Summit
for the benefits that the negotiations could bring to the medtech
sector on both sides of the Atlantic.
US and EU leaders announced that talks on the Transatlantic Trade and
Investment Partnership (TTIP) will start in July. The associations say
that they have been working for several months to urge US and EU
authorities to work toward the inclusion of single audits of medical
device quality systems, a common set of harmonized standards for
marketing application and compliance documentation, a unique device
identification program, elimination of tariffs and improvements in trade
and customs facilitation in the final agreement.
“The industry applauds efforts to begin the TTIP talks. TTIP will
not only promote economic growth in the US and EU, but it also will
help to improve patient outcomes worldwide by improving patient
access to the latest innovative technologies,” said Stephen J. Ubl,
President and CEO of AdvaMed
“We enthusiastically support this opportunity, and look forward
to concrete developments in the coming months that will further
enhance our transatlantic economic relationship, which already
accounts for nearly one trillion dollars in trade and supports
millions of jobs to which David Cameron noted today that TTIP has
the potential to create an additional two million new jobs,” Serge
Bernasconi, Chief Executive Officer of MedTech Europe.
“We are hopeful that this deal will not only to expand trade and
investment between the US and EU, but also improve the global
regulatory environment for manufacturers to ensure they remain at
the forefront of technological innovation,” noted Gail Rodriguez,
Executive Director of MITA.
“The transatlantic medical device community welcomes today’s
announcement, and will continue to work with regulators and trade
negotiators on both sides of the Atlantic to promote increased
safety, quality and access to life-saving medical technologies,”
said Nicole Denjoy, Secretary General of COCIR.